FocusCancer

Tumor-Associated Immune Parameters for Personalized Patient Care

See allHide authors and affiliations

Science Translational Medicine  04 Dec 2013:
Vol. 5, Issue 214, pp. 214fs42
DOI: 10.1126/scitranslmed.3007942

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

The implementation of a robust technology adapted to clinical practice for the evaluation of the tumor-immune infiltrate is required to exploit its prognostic and theranostic value (Robins et al., this issue).

View Full Text